BYAM REBECCA (Chief Financial Officer) purchased 24.5% of their position (8.46K shares) of HCW BIOLOGICS INC. on the open market
Open‑market purchase worth $220.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/9/2025ACC: 0000950170-25-068281
Officer· Chief Financial Officer
Since Jul 2021
+12.69K
Net shares
Net buyer
$220.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
12.69K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+8.46K
Price / share
$26.00
Trade value
$220.01K
% of position
24.5%
5/8/2025
34.55K→43.01K
Total
Net shares
+8.46K
Net value
$220.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/8/2025 | P · Purchase | +8.46K | $26.00 | $220.01K | 24.5% | 34.55K | 43.01K |
| Total | +8.46K | $220.01K | ||||||
Derivative Transactions1
Common Stock Purchase Warrant
Direct
Converts to
Common Stock
4.23K shares
Shares
+4.23K
Strike price
26
Held after
4.23K
Exercisable
—
5/7/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Stock Purchase Warrant Direct | Common Stock4.23K shares | 5/7/2025 | P · Purchase | +4.23K | 26 | — | 4.23K |